Literature DB >> 22899478

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension.

Anastasia Anthi, Iraklis Tsangaris, Eftichia S Hamodraka, John Lekakis, Apostolos Armaganidis, Stylianos E Orfanos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22899478     DOI： 10.1182/blood-2012-04-422568

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Pulmonary arterial hypertension in a patient with β-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literature.

Authors:  Kamonpun Ussavarungsi; Charles D Burger
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

Review 2.  Group 5 Pulmonary Hypertension: The Orphan's Orphan Disease.

Authors:  Sara Kalantari; Mardi Gomberg-Maitland
Journal:  Cardiol Clin       Date:  2016-08       Impact factor: 2.213

3.  Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.

Authors:  Sylvia T Singer; Frans Kuypers; Jeffery Fineman; Ginny Gildengorin; Sandra Larkin; Nancy Sweeters; Howard Rosenfeld; Gregory Kurio; Annie Higa; Michael Jeng; James Huang; Elliott P Vichinsky
Journal:  Ann Hematol       Date:  2014-02-28       Impact factor: 3.673

Review 4.  Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.

Authors:  Roberto F Machado; Harrison W Farber
Journal:  Clin Chest Med       Date:  2013-10-17       Impact factor: 2.878

Review 5.  Pulmonary hypertension associated with thalassemia syndromes.

Authors:  Dustin R Fraidenburg; Roberto F Machado
Journal:  Ann N Y Acad Sci       Date:  2016-03-23       Impact factor: 5.691

Review 6.  How I treat hypoxia in adults with hemoglobinopathies and hemolytic disorders.

Authors:  Evans M Machogu; Roberto F Machado
Journal:  Blood       Date:  2018-09-11       Impact factor: 22.113

7.  Effect of acetylsalicylic acid on thalassemia with pulmonary arterial hypertension.

Authors:  Nonlawan Chueamuangphan; Wattana Wongtheptian; Jayanton Patumanond; Apichard Sukonthasarn; Suporn Chuncharunee; Chamaiporn Tawichasri; Weerasak Nawarawong
Journal:  Int J Gen Med       Date:  2014-12-03

8.  Treatment of pulmonary hypertension in three patients with ß-thalassemia intermedia using pulmonary arterial hypertension-specific medications.

Authors:  Demet Menekşe Gerede; Aynur Acıbuca; Tamer Sayın; Çetin Erol
Journal:  Anatol J Cardiol       Date:  2016-01       Impact factor: 1.596

9.  The improvement of pulmonary artery pressure after bosentan therapy in patients with β-thalassemia and Doppler-defined pulmonary arterial hypertension.

Authors:  Hossein Karami; Hadi Darvishi-Khezri; Mehrnoush Kosaryan; Rosetta Akbarzadeh; Mojdeh Dabirian
Journal:  Int Med Case Rep J       Date:  2018-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.